Loading icon
Three MS Studies on a Gene, Plasma Lipids and Lifestyle
Three MS Studies on a Gene, Plasma Lipids and Lifestyle

Three MS studies measured two things in the same people, and the two readings disagree. De Meo and colleagues followed 97 patients for eight years, where BDNF Val66Met carriers ran a lower hazard of relapse-independent progression while accruing lesions and losing brain, white matter and spinal cord volume faster. Fung and colleagues measured thirty-five plasma lipid mediators in a Dutch birth-year cohort, where six differed between men and women with MS and their correlations with disability, neurofilament and brain volume ran in different directions. Gravesteijn and colleagues report the 24-month results of a digital lifestyle programme in 659 people.

Read more